Data as of Apr 15
| +0.04 / +0.30%|
The 21 analysts offering 12-month price forecasts for Boston Scientific Corp have a median target of 14.00, with a high estimate of 18.00 and a low estimate of 10.00. The median estimate represents a +4.87% increase from the last price of 13.35.
The current consensus among 24 polled investment analysts is to Buy stock in Boston Scientific Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.